nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—Etoposide—sarcoma	0.188	0.386	CbGbCtD
Triamcinolone—CYP3A4—Thiotepa—sarcoma	0.137	0.281	CbGbCtD
Triamcinolone—CYP3A4—Mitoxantrone—sarcoma	0.0591	0.121	CbGbCtD
Triamcinolone—CYP3A4—Vincristine—sarcoma	0.0407	0.0832	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—sarcoma	0.0373	0.0763	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—sarcoma	0.0254	0.052	CbGbCtD
Triamcinolone—BCHE—diaphragm—sarcoma	0.023	0.159	CbGeAlD
Triamcinolone—PTGS2—periosteum—sarcoma	0.0102	0.0705	CbGeAlD
Triamcinolone—PTGS2—leg—sarcoma	0.00814	0.0562	CbGeAlD
Triamcinolone—PTGS2—hindlimb—sarcoma	0.00727	0.0502	CbGeAlD
Triamcinolone—PTGS2—cartilage tissue—sarcoma	0.00716	0.0494	CbGeAlD
Triamcinolone—PTGS2—appendage—sarcoma	0.00624	0.043	CbGeAlD
Triamcinolone—SERPINA6—hematopoietic system—sarcoma	0.00488	0.0337	CbGeAlD
Triamcinolone—PTGS2—endothelium—sarcoma	0.00376	0.026	CbGeAlD
Triamcinolone—SERPINA6—bone marrow—sarcoma	0.00313	0.0216	CbGeAlD
Triamcinolone—BCHE—myometrium—sarcoma	0.00279	0.0193	CbGeAlD
Triamcinolone—SERPINA6—liver—sarcoma	0.00253	0.0174	CbGeAlD
Triamcinolone—BCHE—seminal vesicle—sarcoma	0.00252	0.0174	CbGeAlD
Triamcinolone—NR3C1—myometrium—sarcoma	0.00249	0.0172	CbGeAlD
Triamcinolone—BCHE—hematopoietic system—sarcoma	0.0024	0.0166	CbGeAlD
Triamcinolone—NR3C1—embryo—sarcoma	0.00239	0.0165	CbGeAlD
Triamcinolone—NR3C1—seminal vesicle—sarcoma	0.00225	0.0155	CbGeAlD
Triamcinolone—PTGS2—myometrium—sarcoma	0.00215	0.0149	CbGeAlD
Triamcinolone—NR3C1—hematopoietic system—sarcoma	0.00214	0.0147	CbGeAlD
Triamcinolone—BCHE—smooth muscle tissue—sarcoma	0.00211	0.0146	CbGeAlD
Triamcinolone—BCHE—skin of body—sarcoma	0.00209	0.0144	CbGeAlD
Triamcinolone—PTGS2—embryo—sarcoma	0.00207	0.0143	CbGeAlD
Triamcinolone—NR3C1—connective tissue—sarcoma	0.00206	0.0142	CbGeAlD
Triamcinolone—PTGS2—seminal vesicle—sarcoma	0.00195	0.0134	CbGeAlD
Triamcinolone—NR3C1—smooth muscle tissue—sarcoma	0.00188	0.013	CbGeAlD
Triamcinolone—NR3C1—skin of body—sarcoma	0.00186	0.0128	CbGeAlD
Triamcinolone—PTGS2—hematopoietic system—sarcoma	0.00185	0.0128	CbGeAlD
Triamcinolone—BCHE—cardiac atrium—sarcoma	0.00182	0.0126	CbGeAlD
Triamcinolone—BCHE—uterus—sarcoma	0.00181	0.0125	CbGeAlD
Triamcinolone—PTGS2—connective tissue—sarcoma	0.00178	0.0123	CbGeAlD
Triamcinolone—PTGS2—smooth muscle tissue—sarcoma	0.00163	0.0112	CbGeAlD
Triamcinolone—NR3C1—cardiac atrium—sarcoma	0.00162	0.0112	CbGeAlD
Triamcinolone—CYP3A4—hematopoietic system—sarcoma	0.00162	0.0112	CbGeAlD
Triamcinolone—NR3C1—uterus—sarcoma	0.00161	0.0111	CbGeAlD
Triamcinolone—PTGS2—skin of body—sarcoma	0.00161	0.0111	CbGeAlD
Triamcinolone—BCHE—bone marrow—sarcoma	0.00154	0.0106	CbGeAlD
Triamcinolone—NR3C1—lymphoid tissue—sarcoma	0.0015	0.0104	CbGeAlD
Triamcinolone—NR3C1—tendon—sarcoma	0.00141	0.00976	CbGeAlD
Triamcinolone—PTGS2—uterus—sarcoma	0.0014	0.00964	CbGeAlD
Triamcinolone—NR3C1—bone marrow—sarcoma	0.00137	0.00945	CbGeAlD
Triamcinolone—BCHE—testis—sarcoma	0.00131	0.00908	CbGeAlD
Triamcinolone—PTGS2—lymphoid tissue—sarcoma	0.0013	0.00898	CbGeAlD
Triamcinolone—BCHE—liver—sarcoma	0.00124	0.00858	CbGeAlD
Triamcinolone—PTGS2—tendon—sarcoma	0.00122	0.00845	CbGeAlD
Triamcinolone—PTGS2—bone marrow—sarcoma	0.00119	0.00818	CbGeAlD
Triamcinolone—NR3C1—testis—sarcoma	0.00117	0.00808	CbGeAlD
Triamcinolone—NR3C1—liver—sarcoma	0.00111	0.00764	CbGeAlD
Triamcinolone—PTGS2—liver—sarcoma	0.000958	0.00661	CbGeAlD
Triamcinolone—BCHE—lymph node—sarcoma	0.000953	0.00658	CbGeAlD
Triamcinolone—Fluid retention—Doxorubicin—sarcoma	0.000905	0.00247	CcSEcCtD
Triamcinolone—Infection—Dactinomycin—sarcoma	0.0009	0.00245	CcSEcCtD
Triamcinolone—Ill-defined disorder—Mitoxantrone—sarcoma	0.000896	0.00244	CcSEcCtD
Triamcinolone—Neuropathy—Doxorubicin—sarcoma	0.000895	0.00244	CcSEcCtD
Triamcinolone—Vertigo—Vincristine—sarcoma	0.000891	0.00243	CcSEcCtD
Triamcinolone—Tachycardia—Thiotepa—sarcoma	0.000891	0.00243	CcSEcCtD
Triamcinolone—Malaise—Mitoxantrone—sarcoma	0.000871	0.00237	CcSEcCtD
Triamcinolone—Thrombophlebitis—Epirubicin—sarcoma	0.000864	0.00235	CcSEcCtD
Triamcinolone—Ecchymosis—Doxorubicin—sarcoma	0.000862	0.00235	CcSEcCtD
Triamcinolone—Diabetes mellitus—Epirubicin—sarcoma	0.00086	0.00234	CcSEcCtD
Triamcinolone—Convulsion—Vincristine—sarcoma	0.000859	0.00234	CcSEcCtD
Triamcinolone—Hypertension—Vincristine—sarcoma	0.000856	0.00233	CcSEcCtD
Triamcinolone—NR3C1—lymph node—sarcoma	0.000849	0.00586	CbGeAlD
Triamcinolone—Pulmonary oedema—Doxorubicin—sarcoma	0.000848	0.00231	CcSEcCtD
Triamcinolone—Myalgia—Vincristine—sarcoma	0.000844	0.0023	CcSEcCtD
Triamcinolone—Cough—Mitoxantrone—sarcoma	0.000843	0.0023	CcSEcCtD
Triamcinolone—CYP3A4—liver—sarcoma	0.000837	0.00578	CbGeAlD
Triamcinolone—Convulsion—Mitoxantrone—sarcoma	0.000837	0.00228	CcSEcCtD
Triamcinolone—Vascular purpura—Epirubicin—sarcoma	0.000836	0.00228	CcSEcCtD
Triamcinolone—Hypertension—Mitoxantrone—sarcoma	0.000834	0.00227	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000831	0.00227	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000825	0.00225	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Epirubicin—sarcoma	0.000824	0.00225	CcSEcCtD
Triamcinolone—Myalgia—Mitoxantrone—sarcoma	0.000822	0.00224	CcSEcCtD
Triamcinolone—Paraesthesia—Thiotepa—sarcoma	0.000819	0.00223	CcSEcCtD
Triamcinolone—Discomfort—Mitoxantrone—sarcoma	0.000812	0.00221	CcSEcCtD
Triamcinolone—Anaphylactic shock—Vincristine—sarcoma	0.000809	0.00221	CcSEcCtD
Triamcinolone—Oedema—Vincristine—sarcoma	0.000809	0.00221	CcSEcCtD
Triamcinolone—Infection—Vincristine—sarcoma	0.000804	0.00219	CcSEcCtD
Triamcinolone—Dyspepsia—Thiotepa—sarcoma	0.000803	0.00219	CcSEcCtD
Triamcinolone—Thrombophlebitis—Doxorubicin—sarcoma	0.000799	0.00218	CcSEcCtD
Triamcinolone—Increased appetite—Epirubicin—sarcoma	0.000796	0.00217	CcSEcCtD
Triamcinolone—Diabetes mellitus—Doxorubicin—sarcoma	0.000795	0.00217	CcSEcCtD
Triamcinolone—Oedema—Mitoxantrone—sarcoma	0.000788	0.00215	CcSEcCtD
Triamcinolone—Anaphylactic shock—Mitoxantrone—sarcoma	0.000788	0.00215	CcSEcCtD
Triamcinolone—Fatigue—Thiotepa—sarcoma	0.000787	0.00215	CcSEcCtD
Triamcinolone—Dysgeusia—Etoposide—sarcoma	0.000787	0.00214	CcSEcCtD
Triamcinolone—Infection—Mitoxantrone—sarcoma	0.000783	0.00213	CcSEcCtD
Triamcinolone—Hyperhidrosis—Vincristine—sarcoma	0.000782	0.00213	CcSEcCtD
Triamcinolone—Dermatitis bullous—Epirubicin—sarcoma	0.000782	0.00213	CcSEcCtD
Triamcinolone—Fatigue—Dactinomycin—sarcoma	0.000781	0.00213	CcSEcCtD
Triamcinolone—Pain—Thiotepa—sarcoma	0.00078	0.00213	CcSEcCtD
Triamcinolone—Back pain—Etoposide—sarcoma	0.000777	0.00212	CcSEcCtD
Triamcinolone—Purpura—Epirubicin—sarcoma	0.000776	0.00211	CcSEcCtD
Triamcinolone—Shock—Mitoxantrone—sarcoma	0.000775	0.00211	CcSEcCtD
Triamcinolone—Pain—Dactinomycin—sarcoma	0.000775	0.00211	CcSEcCtD
Triamcinolone—Vascular purpura—Doxorubicin—sarcoma	0.000773	0.00211	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Epirubicin—sarcoma	0.000772	0.00211	CcSEcCtD
Triamcinolone—Tachycardia—Mitoxantrone—sarcoma	0.000769	0.0021	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000763	0.00208	CcSEcCtD
Triamcinolone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000762	0.00208	CcSEcCtD
Triamcinolone—Feeling abnormal—Thiotepa—sarcoma	0.000752	0.00205	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—sarcoma	0.000748	0.00204	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—sarcoma	0.000746	0.00203	CcSEcCtD
Triamcinolone—Ill-defined disorder—Etoposide—sarcoma	0.000745	0.00203	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000737	0.00201	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—sarcoma	0.000736	0.00201	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—sarcoma	0.000736	0.00201	CcSEcCtD
Triamcinolone—PTGS2—lymph node—sarcoma	0.000734	0.00507	CbGeAlD
Triamcinolone—Insomnia—Vincristine—sarcoma	0.000732	0.002	CcSEcCtD
Triamcinolone—Paraesthesia—Vincristine—sarcoma	0.000727	0.00198	CcSEcCtD
Triamcinolone—Urticaria—Thiotepa—sarcoma	0.000725	0.00198	CcSEcCtD
Triamcinolone—Malaise—Etoposide—sarcoma	0.000724	0.00197	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—sarcoma	0.000724	0.00197	CcSEcCtD
Triamcinolone—Vertigo—Etoposide—sarcoma	0.000722	0.00197	CcSEcCtD
Triamcinolone—Body temperature increased—Thiotepa—sarcoma	0.000721	0.00197	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000718	0.00196	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—sarcoma	0.000718	0.00196	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—sarcoma	0.000716	0.00195	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000715	0.00195	CcSEcCtD
Triamcinolone—Cardiac arrest—Epirubicin—sarcoma	0.000711	0.00194	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—sarcoma	0.000708	0.00193	CcSEcCtD
Triamcinolone—Paraesthesia—Mitoxantrone—sarcoma	0.000708	0.00193	CcSEcCtD
Triamcinolone—Loss of consciousness—Etoposide—sarcoma	0.000706	0.00192	CcSEcCtD
Triamcinolone—Dyspnoea—Mitoxantrone—sarcoma	0.000703	0.00192	CcSEcCtD
Triamcinolone—Cough—Etoposide—sarcoma	0.000701	0.00191	CcSEcCtD
Triamcinolone—Fatigue—Vincristine—sarcoma	0.000698	0.0019	CcSEcCtD
Triamcinolone—Convulsion—Etoposide—sarcoma	0.000696	0.0019	CcSEcCtD
Triamcinolone—Dyspepsia—Mitoxantrone—sarcoma	0.000694	0.00189	CcSEcCtD
Triamcinolone—Hypertension—Etoposide—sarcoma	0.000693	0.00189	CcSEcCtD
Triamcinolone—Pain—Vincristine—sarcoma	0.000692	0.00189	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—sarcoma	0.000692	0.00189	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—sarcoma	0.000681	0.00186	CcSEcCtD
Triamcinolone—Fatigue—Mitoxantrone—sarcoma	0.000679	0.00185	CcSEcCtD
Triamcinolone—Discomfort—Etoposide—sarcoma	0.000676	0.00184	CcSEcCtD
Triamcinolone—Pain—Mitoxantrone—sarcoma	0.000674	0.00184	CcSEcCtD
Triamcinolone—Hypersensitivity—Thiotepa—sarcoma	0.000672	0.00183	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—sarcoma	0.000667	0.00182	CcSEcCtD
Triamcinolone—Muscular weakness—Epirubicin—sarcoma	0.000659	0.0018	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—sarcoma	0.000658	0.00179	CcSEcCtD
Triamcinolone—Anaphylactic shock—Etoposide—sarcoma	0.000656	0.00179	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—sarcoma	0.000655	0.00179	CcSEcCtD
Triamcinolone—Asthenia—Thiotepa—sarcoma	0.000655	0.00179	CcSEcCtD
Triamcinolone—Infection—Etoposide—sarcoma	0.000651	0.00178	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—sarcoma	0.00065	0.00177	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—sarcoma	0.00065	0.00177	CcSEcCtD
Triamcinolone—Feeling abnormal—Mitoxantrone—sarcoma	0.000649	0.00177	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—sarcoma	0.000646	0.00176	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—sarcoma	0.000646	0.00176	CcSEcCtD
Triamcinolone—Pruritus—Thiotepa—sarcoma	0.000646	0.00176	CcSEcCtD
Triamcinolone—Tachycardia—Etoposide—sarcoma	0.00064	0.00174	CcSEcCtD
Triamcinolone—Body temperature increased—Vincristine—sarcoma	0.00064	0.00174	CcSEcCtD
Triamcinolone—Hyperhidrosis—Etoposide—sarcoma	0.000634	0.00173	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—sarcoma	0.000634	0.00173	CcSEcCtD
Triamcinolone—Urticaria—Mitoxantrone—sarcoma	0.000626	0.00171	CcSEcCtD
Triamcinolone—Body temperature increased—Mitoxantrone—sarcoma	0.000623	0.0017	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—sarcoma	0.000621	0.00169	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—sarcoma	0.00061	0.00166	CcSEcCtD
Triamcinolone—Dizziness—Thiotepa—sarcoma	0.000603	0.00165	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—sarcoma	0.000602	0.00164	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000601	0.00164	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—sarcoma	0.000598	0.00163	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—sarcoma	0.000598	0.00163	CcSEcCtD
Triamcinolone—Hypersensitivity—Vincristine—sarcoma	0.000596	0.00163	CcSEcCtD
Triamcinolone—Paraesthesia—Etoposide—sarcoma	0.000589	0.0016	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—sarcoma	0.000588	0.0016	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—sarcoma	0.000586	0.0016	CcSEcCtD
Triamcinolone—Dyspnoea—Etoposide—sarcoma	0.000584	0.00159	CcSEcCtD
Triamcinolone—Hypersensitivity—Mitoxantrone—sarcoma	0.000581	0.00158	CcSEcCtD
Triamcinolone—Asthenia—Vincristine—sarcoma	0.000581	0.00158	CcSEcCtD
Triamcinolone—Vomiting—Thiotepa—sarcoma	0.00058	0.00158	CcSEcCtD
Triamcinolone—Vomiting—Dactinomycin—sarcoma	0.000576	0.00157	CcSEcCtD
Triamcinolone—Rash—Thiotepa—sarcoma	0.000575	0.00157	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—sarcoma	0.000575	0.00157	CcSEcCtD
Triamcinolone—Dermatitis—Thiotepa—sarcoma	0.000575	0.00157	CcSEcCtD
Triamcinolone—Headache—Thiotepa—sarcoma	0.000572	0.00156	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—sarcoma	0.000571	0.00156	CcSEcCtD
Triamcinolone—Asthenia—Mitoxantrone—sarcoma	0.000565	0.00154	CcSEcCtD
Triamcinolone—Fatigue—Etoposide—sarcoma	0.000565	0.00154	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—sarcoma	0.000565	0.00154	CcSEcCtD
Triamcinolone—Pain—Etoposide—sarcoma	0.000561	0.00153	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—sarcoma	0.00056	0.00153	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000556	0.00151	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—sarcoma	0.000544	0.00148	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—sarcoma	0.000543	0.00148	CcSEcCtD
Triamcinolone—Nausea—Thiotepa—sarcoma	0.000542	0.00148	CcSEcCtD
Triamcinolone—Feeling abnormal—Etoposide—sarcoma	0.00054	0.00147	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—sarcoma	0.000538	0.00147	CcSEcCtD
Triamcinolone—Dizziness—Vincristine—sarcoma	0.000535	0.00146	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—sarcoma	0.000527	0.00144	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000523	0.00142	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—sarcoma	0.000521	0.00142	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—sarcoma	0.00052	0.00142	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—sarcoma	0.000519	0.00141	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—sarcoma	0.000518	0.00141	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—sarcoma	0.000518	0.00141	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—sarcoma	0.000517	0.00141	CcSEcCtD
Triamcinolone—Vomiting—Vincristine—sarcoma	0.000515	0.0014	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—sarcoma	0.000513	0.0014	CcSEcCtD
Triamcinolone—Rash—Vincristine—sarcoma	0.00051	0.00139	CcSEcCtD
Triamcinolone—Dermatitis—Vincristine—sarcoma	0.00051	0.00139	CcSEcCtD
Triamcinolone—Headache—Vincristine—sarcoma	0.000507	0.00138	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—sarcoma	0.000503	0.00137	CcSEcCtD
Triamcinolone—Vomiting—Mitoxantrone—sarcoma	0.000501	0.00137	CcSEcCtD
Triamcinolone—Rash—Mitoxantrone—sarcoma	0.000497	0.00135	CcSEcCtD
Triamcinolone—Dermatitis—Mitoxantrone—sarcoma	0.000496	0.00135	CcSEcCtD
Triamcinolone—Headache—Mitoxantrone—sarcoma	0.000494	0.00135	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—sarcoma	0.000487	0.00133	CcSEcCtD
Triamcinolone—Hypersensitivity—Etoposide—sarcoma	0.000483	0.00132	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—sarcoma	0.000481	0.00131	CcSEcCtD
Triamcinolone—Nausea—Vincristine—sarcoma	0.000481	0.00131	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—sarcoma	0.00048	0.00131	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—sarcoma	0.000479	0.0013	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—sarcoma	0.000475	0.00129	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—sarcoma	0.00047	0.00128	CcSEcCtD
Triamcinolone—Nausea—Mitoxantrone—sarcoma	0.000468	0.00128	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—sarcoma	0.000464	0.00126	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—sarcoma	0.000462	0.00126	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—sarcoma	0.00045	0.00123	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—sarcoma	0.000441	0.0012	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—sarcoma	0.000436	0.00119	CcSEcCtD
Triamcinolone—Dizziness—Etoposide—sarcoma	0.000433	0.00118	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—sarcoma	0.000428	0.00117	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—sarcoma	0.000418	0.00114	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—sarcoma	0.000417	0.00114	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—sarcoma	0.000417	0.00114	CcSEcCtD
Triamcinolone—Rash—Etoposide—sarcoma	0.000413	0.00113	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—sarcoma	0.000413	0.00113	CcSEcCtD
Triamcinolone—Headache—Etoposide—sarcoma	0.000411	0.00112	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—sarcoma	0.000408	0.00111	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—sarcoma	0.000406	0.00111	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—sarcoma	0.000405	0.0011	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—sarcoma	0.000404	0.0011	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—sarcoma	0.000403	0.0011	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—sarcoma	0.000396	0.00108	CcSEcCtD
Triamcinolone—Cough—Epirubicin—sarcoma	0.000393	0.00107	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—sarcoma	0.00039	0.00106	CcSEcCtD
Triamcinolone—Nausea—Etoposide—sarcoma	0.000389	0.00106	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—sarcoma	0.000389	0.00106	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—sarcoma	0.000387	0.00105	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—sarcoma	0.000383	0.00105	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—sarcoma	0.000379	0.00103	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—sarcoma	0.000376	0.00102	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—sarcoma	0.000375	0.00102	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—sarcoma	0.000374	0.00102	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—sarcoma	0.000374	0.00102	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—sarcoma	0.000367	0.001	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—sarcoma	0.000367	0.001	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—sarcoma	0.000366	0.000998	CcSEcCtD
Triamcinolone—Infection—Epirubicin—sarcoma	0.000365	0.000995	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—sarcoma	0.000364	0.000991	CcSEcCtD
Triamcinolone—Shock—Epirubicin—sarcoma	0.000362	0.000986	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—sarcoma	0.000361	0.000984	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—sarcoma	0.00036	0.000981	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—sarcoma	0.000359	0.000978	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—sarcoma	0.000355	0.000968	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—sarcoma	0.000355	0.000967	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—sarcoma	0.00035	0.000955	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—sarcoma	0.000347	0.000946	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—sarcoma	0.00034	0.000927	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—sarcoma	0.00034	0.000927	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—sarcoma	0.000338	0.000921	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000335	0.000913	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—sarcoma	0.000334	0.000912	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—sarcoma	0.000332	0.000906	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—sarcoma	0.000332	0.000905	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—sarcoma	0.00033	0.0009	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—sarcoma	0.000329	0.000896	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—sarcoma	0.000328	0.000893	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—sarcoma	0.000323	0.000882	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—sarcoma	0.000317	0.000864	CcSEcCtD
Triamcinolone—Pain—Epirubicin—sarcoma	0.000314	0.000857	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00031	0.000845	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—sarcoma	0.000308	0.000838	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—sarcoma	0.000305	0.000832	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—sarcoma	0.000303	0.000826	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—sarcoma	0.000303	0.000826	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—sarcoma	0.000299	0.000816	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—sarcoma	0.000293	0.000799	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—sarcoma	0.000292	0.000796	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—sarcoma	0.000291	0.000793	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—sarcoma	0.00029	0.000792	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—sarcoma	0.00028	0.000764	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—sarcoma	0.000271	0.000738	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—sarcoma	0.00027	0.000736	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—sarcoma	0.000269	0.000733	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—sarcoma	0.000264	0.000719	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—sarcoma	0.00026	0.000709	CcSEcCtD
Triamcinolone—Hypersensitivity—Doxorubicin—sarcoma	0.00025	0.000683	CcSEcCtD
Triamcinolone—Asthenia—Doxorubicin—sarcoma	0.000244	0.000665	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—sarcoma	0.000243	0.000662	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—sarcoma	0.000241	0.000656	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—sarcoma	0.000234	0.000637	CcSEcCtD
Triamcinolone—Rash—Epirubicin—sarcoma	0.000232	0.000632	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—sarcoma	0.000231	0.000631	CcSEcCtD
Triamcinolone—Headache—Epirubicin—sarcoma	0.00023	0.000628	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—sarcoma	0.000225	0.000613	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—sarcoma	0.000218	0.000595	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—sarcoma	0.000216	0.000589	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—sarcoma	0.000214	0.000584	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—sarcoma	0.000214	0.000584	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—sarcoma	0.000213	0.000581	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—sarcoma	0.000202	0.000551	CcSEcCtD
